incucyte system (Sartorius AG)
Sartorius AG is a verified supplier 
Sartorius AG manufactures this product 
99
Structured Review
Sartorius AG
incucyte system
Incucyte System, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 16012 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/live+cell+analysis+instruments/Live+Cell+Analysis+Instruments/pm42826203-308-9-11
Average 99 stars, based on 16012 article reviews
Incucyte System, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 16012 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/live+cell+analysis+instruments/Live+Cell+Analysis+Instruments/pm42826203-308-9-11
Average 99 stars, based on 16012 article reviews
incucyte system - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Titration:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Sensitivity:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Virus:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Analysis:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Neutralization:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Software:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Concentration Assay:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Incubation:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Antibody Labeling:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Labeling:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Cell Culture:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Magnetic Cell Separation:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Transduction:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Selection:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Activity Assay:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using Microscopy:Article Title: Leishmania and phlebovirus seroprevalence in dogs in two non-endemic central European countries: Austria and Germany Article Snippet: included TCID 50 assay for viral titration confirmation. After 5 days for TOSV and 6 days for SFSV, photos of each well of the 96-well microplates were taken by using |
![CLSP-1025 demonstrates functional activity in various cellular systems including cell cocultures and patient-derived organoids. A, CLSP-1025–mediated cytotoxicity in cocultures of PBMCs and HLA-A*02:01 + –p53 R175H+ tumor cells. Cytotoxicity is reported as the percent tumor-cell death after a 96-hour coculture (mean ± SEM; n = 2). B, HLA-A*02:01 surface expression on p53 R175H+ TYK-nu cells after 72 hours of IFN-γ treatment, measured by geometric mean fluorescence intensity (gMFI) via flow cytometry. Data shown as mean; n = 3 technical replicates. C, CLSP-1025–mediated cytotoxicity in PBMC cocultures with TYK-nu cells with or without IFN-γ pretreatment, shown as percent tumor-cell death (mean ± SEM; n = 3 technical replicates). D–E, CLSP-1025–mediated cytotoxicity and IFN-γ secretion in PBMC cocultures with HLA-A*02:01 + –p53 R175H + adenocarcinoma organoids, measured by percent tumor-cell death and MSD, respectively [mean ± standard deviation (SD); n = 1 PBMC donor and technical duplicates for IFN-γ measurements]. F and G, CLSP-1025–mediated cytotoxicity and IFN-γ secretion in PBMC cocultures with HLA-A*02:01 + –p53 WT adenocarcinoma organoids. H, CLSP-1025–mediated killing of GFP + KLE cells when cocultured with isolated CD4 + , CD8 + , or bulk CD3 + T cells. GFP signal was quantified in real time using <t>Incucyte</t> and plotted as normalized fluorescence units [GFP fluorescence units (GFU) × μm 2 /image]. Data shown as mean ± SD; n = 2 technical replicates.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8097/pmc13628097/pmc13628097__ccr-26-1252_f2.jpg)
